The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes

J Med Screen. 2015 Jun;22(2):106-8. doi: 10.1177/0969141315572173. Epub 2015 Mar 9.

Abstract

Objective: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study aims to quantify the proportion of non-participants who have a medical reason for not attending cancer screening.

Methods: Medical reasons for not participating in breast and bowel screening were defined a priori on the basis of a literature review and expert opinion. The notes of 700 patients at two GP practices in Scotland were reviewed, to ascertain the prevalence of medical reasons amongst non-participants. Simple proportions and confidence intervals were calculated.

Results: 17.4% of breast and 2.3% of bowel screening non-participants had a medical reason to not participate. The two most common reasons were previous breast cancer follow up (8.86%) and recent mammogram (6.57%).

Conclusion: These patients may not benefit from screening while also being distressed by receiving an invitation. This issue also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly the extent to which medical reasons account for screening non-participation in a larger population.

Keywords: Attendance; Bowel; Breast; Scotland; Screening; non-participation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / epidemiology
  • Comorbidity
  • Early Detection of Cancer*
  • Female
  • Humans
  • Intestinal Neoplasms / diagnosis*
  • Intestinal Neoplasms / epidemiology
  • Mammography
  • Mass Screening / statistics & numerical data*
  • Patient Participation / statistics & numerical data*
  • Prevalence
  • Scotland